Central tolerance is the first line of defense against self-reactivity. In the thymus, developing T cells are tested against self-peptides displayed on MHC molecules by thymic epithelial cells and dendritic cells. A T cell whose receptor binds self-peptide too strongly receives a strong signal and is eliminated by apoptosis, a process called negative selection. A weaker interaction may instead divert the cell into the regulatory T cell lineage, converting a potential threat into a suppressor. B cells undergo an analogous process in the bone marrow, where strongly self-reactive B cells can be deleted or edit their receptor through light-chain replacement.
The critical limitation is coverage. Negative selection can only remove lymphocytes that encounter their self-antigen in the thymus or bone marrow. Many tissue-restricted proteins are expressed at low levels or not at all in these organs, so lymphocytes specific for them survive and enter the circulation. Central tolerance is therefore a strong but incomplete filter, and the escapees are the raw material for autoimmunity if peripheral tolerance later fails.